
AstraZeneca challenges Roche on frontline SCLC after seizing an interim win — and Merck may not be far behind Endpoints News
“This is the first trial offering the flexibility of combining immunotherapy with different platinum-based regimens in small cell lung cancer, expanding treatment …
